Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$126.46 - $235.05 $107,617 - $200,027
-851 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$225.82 - $368.51 $192,172 - $313,602
851 New
851 $216,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Royal Capital Wealth Management, LLC Portfolio

Follow Royal Capital Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Capital Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Royal Capital Wealth Management, LLC with notifications on news.